- Report
- February 2020
- 94 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
- Report
- February 2020
- 82 Pages
North America
From €1450EUR$1,500USD£1,246GBP
- Report
- October 2023
- 112 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- July 2023
- 86 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- July 2023
- 98 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- February 2024
- 169 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- September 2021
- 212 Pages
Global
From €5963EUR$6,168USD£5,122GBP
- Report
- July 2023
- 140 Pages
Global
From €5800EUR$5,999USD£4,982GBP
The Human Growth Hormone (HGH) market is a segment of the Endocrine and Metabolic Disorders Drugs market. HGH is a hormone produced by the pituitary gland that is responsible for growth and development in humans. It is used to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. HGH is also used to improve athletic performance and to treat age-related conditions such as osteoporosis and muscle wasting.
HGH is available in both injectable and oral forms, and is typically prescribed by endocrinologists. The market for HGH is expected to grow due to the increasing prevalence of endocrine and metabolic disorders, as well as the growing demand for performance-enhancing drugs.
Some of the major companies in the HGH market include Pfizer, Novo Nordisk, Eli Lilly, Merck, and Sanofi. Show Less Read more